drugset / Trial / NCT01096810

Study of TBL 12 Sea Cucumber Extract for Patients With Untreated Asymptomatic Myeloma

NCT01096810 ↗

NaSingle-groupOpen-labelTreatment

Summary

Purpose: The purpose of this study is to see if TBL 12, which is a blend of Sea Cucumber, Sea Sponge, Shark Fin, and Sea Urchin (animals that live in the Pacific Ocean) as well as Sargassum (a plant that lives in the Pacific Ocean), will have effects against asymptomatic multiple myeloma and to see what the side effects are. Eligibility: Several criteria must be met to be eligible for this study, including but not limited to the following: * a diagnosis of asymptomatic multiple myeloma * adequate cardiac, liver and kidney function * age 18 and older

Timeline

Start
2008-09
Primary completion
2014-03
Completion
2014-03

Outcome

Outcome not reported

Stopped (Enrollment): “The research is permanently closed to enrollment.”

Drugs

EvaluationDrugModalityDoseRoute
Subject TBL12 Unknown 40 ml Oral

Indications